Consistent with these data, CD34+ stem cells from CML patients with complete cytogenetic responses were found to be of malignant origin with the capacity to give rise to CML-BC (Bhatia et al., 2003). Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.